How Life Line Screening Is Transforming the Healthcare Sector

Life Line Screening is a prevention and wellness clinic established in 1993 in Austin, TX. The organization offers community-based screening services for people across America. Over the years, the company has expanded across UK and USA. It has added finger-stick blood test method to the testing services to check for complete cholesterol count, inflammation, and diabetes.

The lab launched its services in the United Kingdom in 2007. The following year, the clinic expanded and added atrial fibrillation screenings. In 2012, it joined the Australian market using the name Screen for Life. It has collaborated with many hospitals, insurance companies, and nonprofit organizations to provide quality and affordable screening services to the public.


Across the world, the firm has completed over 8 million screenings since it was founded that include blood screenings, electrocardiographs, and ultrasound scans. They organize local community events to deliver the services to patients who cannot make it to the facility. Scholars have confirmed that the screenings are healthy and fit for the human body. The Better Bureau accredited the organization in 1996.

Screening Preparation

All the ultrasounds offered at the center are painless and non-invasive. The tests require little or no preparation at all. You do not need to fast or wearing short sleeves or loose clothing. Medical practitioners at Life Line Screening try to make the procedure easy for their clients.

What to Wear

For a process to test carotid artery disease (stroke) make sure you put on a short-sleeved shirt open at the collar and avoid turtleneck. Testing for atrial fibrillation requires that you wear loose clothing and avoid putting on a watch or pantyhose. Switch off your cell phone and do not apply oil or lotion.

What to expect

During a screening exam, the sonographer will guide you in changing your clothes to hospital attire. They will take the sample that can be urine, saliva, blood, or hair for examination. Different procedures take different time to give results.

Benefits of Screening

Every ultrasound aids in finding a disease early and its cause. Technicians compile a report about what they observe and send it to the doctor. Your practitioner will advise on the steps to take depending on the results.

To know more visit @:

Oncotarget Sees Surge in Help for Oncologists

While Oncotarget is available for any type of specialists who needs the help of the research, it is geared toward oncologists who are looking for help in different situations. Mikhail Blagosklonny knows that the peer review publication that he started is something that he can benefit from and something that other people are able to do. He tries to make sure that he can help people with their issues and that Oncotarget is doing what they can to make things better. While he has always had a huge part in the way that the publication works, he is going to continue to do even more with the experiences that he has now that he can try different things.

For Oncotarget to offer people the help that they need, they need to make sure that they are using the things that will make their practices better.Since Oncotarget first started, it has been helping people who are in different situations. Mikhail Blagosklonny knows that the publication will be enough to help other people out and that it will be something that people can benefit from. He is always working to make sure that the people are going to be able to make things better and that they are going to help their patients. He has always been interested in making things happen for the business and making it easier for them to make all of the right choices.

Oncotarget continues to be a great option for people who are trying different things in their careers and with the research that they have learned about.One thing that Oncotarget always does is make sure that people are learning everything that they can about different health issues. This is great for doctors who are already specialists but it is even better for students who are working to become doctors. Oncotarget has grown in the time that they have been trying different things and people are now able to learn more about what they can get from the research materials. It is something that has set Oncotarget apart from other publications and made them easier for people to use.

Jim Tananbaum Adds A Vital Player To His Foresite Capital’s Team

Foresite Capital recently added the great mind of Dr. Molly He to their able team as a Venture Partner. Remarking on the new development, Foresite Capital’s M.D. and chief executive officer, Jim Tananbaum, excitedly noted that the team was thrilled to welcome the highly valued next-generation sequencing researcher. He further added that Dr. He would be a vital resource to the continually expanding firm following her expertise and impeccable leadership skills. Dr. He noted that she was privileged to join and take part in the evolution of Foresite’s next-generation sequencing.

Worthy Experience

Dr. He brought Foresite an experience of over 15 years in development and research of genomics and drug development practices. The first couple of years of her research career were in the pharmaceutical field where she focused on cancer and immune diseases. She researched and developed antibody and small molecule drugs for the two. Dr. He then moved to Pacific Biosciences and later Illumina. She was mandated with the role of creating and improving protein reagents for both firms. Her impeccable performance in her roles has been due to solid training that she received at Nankai University and the University of California where she earned a bachelor’s degree in biochemistry and a Ph.D. in protein biophysics respectively. Dr. He owns 20 patents and over 20 published research papers.

Foresite Capital

Foresite Capital helps up-coming public and private healthcare providers grow their capital. It mainly focuses on healthcare firms with disruptive products. The company is located in San Francisco and also runs an office in New York.

About Jim Tananbaum

Jim Tananbaum attended Yale University for his BS and BSEE in mathematics and computer science. Soon after, Jim joined the notable Massachusetts Institute of Technology and pursued a master’s degree in HST information theory. Jim further went to Harvard Medical School and Harvard Business School where he attained his MD and MBA respectively.

Jim Tananbaum co-founded and worked for GelTex in 1991, which was later sold to Genzyme. He moved to Sierra Ventures as a partner where he developed healthcare investment service. Jim co-founded several other ventures, such as Theravance and Prospect Venture Partners. In 2010, he launched Foresite Capital Management, which he currently runs as the CEO.

Read more:

Follow him on Twitter